# A Study to Compare a New Eye Drop Formulation With Systane® Gel Drops and Genteal® Lubricant Gel Drops for Moderate to Severe Dry Eye Relief

> **NCT02455050** · PHASE3 · COMPLETED · sponsor: **Allergan** · enrollment: 79 (actual)

## Conditions studied

- Dry Eye Syndromes

## Interventions

- **DRUG:** Carboxymethylcellulose Sodium Based Eye Drops
- **DRUG:** Systane® Gel Drops
- **DRUG:** Genteal® Lubricant Gel Drops

## Key facts

- **NCT ID:** NCT02455050
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2017-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02455050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02455050, "A Study to Compare a New Eye Drop Formulation With Systane® Gel Drops and Genteal® Lubricant Gel Drops for Moderate to Severe Dry Eye Relief". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02455050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*